赫波利康A通过缓解铁亡,产生神经保护作用
Jia-Le Deng1, Guo-Yan Wang2, Yi-Jie Zhai1
1Shaanxi Key Laboratory of Natural Products & Chemical Biology, College of Chemistry & Pharmacy, Northwest A&F University, No.3 Taicheng Road, Yangling, Shaanxi 712100, China.
来自真菌的赫尔波特里 A (He-A) 通过抑制铁和氧化应激来保护神经退行性疾病. 这种化合物显示出针对神经元损伤的新型治疗策略的前景.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 菌类学 菌类学是指菌类学.
背景情况:
- 神经退行性疾病与氧化应激和铁亡有关.
- 赫波特里康,一种真菌化合物,显示出神经保护的潜力.
- 赫波特里康神经保护的确切机制需要进一步研究.
研究的目的:
- 从 *Herpotrichia* sp. 中分离和鉴定赫波特里康类型的特征. SF09.09 是一个很好的例子.
- 评估herpotrichone A (He-A) 和其类型的神经保护作用.
- 阐明He-A对铁亡神经保护的机制.
主要方法:
- 从*Herpotrichia* sp.中分离出herpotrichones的方法 SF09.09 是一个很好的例子.
- 基于细胞的测定使用PC12和BV-2细胞刺激H2O2,6-OHDA,RSL3和LPS.
- 斑马鱼模型用于评估ferroptotic细胞死亡.
- 对抗氧化元素激活和SLC7A11通路调节的分析.
主要成果:
- 甲 (He-A) 和类似物在刺激细胞系中表现出显著的保护作用.
- 在RSL3治疗的PC12细胞和6-OHDA诱导的斑马鱼中,He-A有效降低了ferroptotic细胞死亡.
- 他-A激活了抗氧化元素,并调节了SLC7A11通路,而无需直接清除激素或铁化.
结论:
- 赫波利康A (He-A) 具有强大的神经保护性,可以抵抗类似铁亡的神经损伤.
- 他-A代表了神经退行性疾病的新治疗候选者.
- 该机制涉及激活抗氧化途径和调节SLC7A11,与直接抗氧化活性不同.
更多相关视频
13:12Partial Optic Nerve Transection in Rats: A Model Established with a New Operative Approach to Assess Secondary Degeneration of Retinal Ganglion Cells
Published on: October 15, 2017
10:33Exploring the Two Herb Combination Strategy to Treat Injured PC12 Cells
Published on: November 18, 2022
相关概念视频
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Drugs Affecting Neurotransmitter Synthesis
Neurochemical Transmission: Sites of Drug Action
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
